Buy Samtica 250 mg Abiraterone Tablets Online
Samtica 250 mg Abiraterone Tablets (1 pack / 120 tabs)
At a Glance
Generic Name: Abiraterone Acetate
Brand Name: Samtica 250 mg
Strength & Pack Size: 250 mg tablets, 1 pack / 120 tablets
Dosage Form & Route: Oral film-coated tablets for swallowing whole
Therapeutic Class: Androgen biosynthesis inhibitor (selective CYP17 inhibitor)
Primary Indications: Metastatic castration-resistant and high-risk metastatic hormone-sensitive prostate cancer, as per local label
Typical Use in Therapy: Given once daily with prednisone or prednisolone on top of ongoing androgen-deprivation therapy
Mode of Action: Selectively inhibits CYP17 to reduce androgen production from testes, adrenals and tumour tissue
Key Benefits: Proven improvement in survival, disease control and symptom burden in carefully selected prostate cancer patients
Precautions: Requires monitoring of liver function, blood pressure, potassium and fluid status; contraindicated in pregnancy and used only in men
Storage: Store below 25 °C in the original blister, protected from moisture and out of children’s reach
Product Description
Samtica 250 mg contains abiraterone acetate, an oral androgen biosynthesis inhibitor used for the treatment of advanced prostate cancer under specialist oncology or uro-oncology supervision. Abiraterone works by selectively inhibiting CYP17, a key enzyme in androgen production, thereby reducing testosterone and other androgens not only from the testes but also from the adrenal glands and within prostate cancer tissue itself.
Each pack of Samtica 250 mg supplied by Generic Meds Mart contains 120 film-coated tablets, designed to be used as part of continuous daily therapy alongside low-dose prednisone or prednisolone and ongoing androgen-deprivation therapy (such as surgical castration or LHRH agonists/antagonists). Depending on your local label and protocol, one pack may correspond to around one month of treatment at the standard daily dose.
Samtica 250 mg abiraterone tablets are typically used either in metastatic castration-resistant prostate cancer, where disease has progressed despite castrate levels of testosterone, or in high-risk metastatic hormone-sensitive prostate cancer, where early intensification improves outcomes. The decision to use abiraterone, and for how long, is always made by a specialist team based on disease stage, comorbidities, prior treatments, access to alternatives and patient preferences. Generic Meds Mart does not replace medical advice; our role is limited to sourcing original Samtica 250 mg packs and managing international logistics where regulations allow.
Generic Meds Mart works only with licensed manufacturers and authorised distributors for Samtica 250 mg. Packs are delivered in original, sealed oncology packaging with visible batch numbers and expiry dates so oncology pharmacies can verify authenticity before dispensing. Outer shipping cartons remain neutral, without visible references to prostate cancer or abiraterone, to preserve patient privacy. Prices are displayed in USD, helping clinics and patients plan the cost of long-term therapy.
Key Uses
Samtica 250 mg abiraterone tablets are used in standard guideline-based prostate cancer treatment indications, which may include:
- Metastatic castration-resistant prostate cancer (mCRPC) in men whose disease has progressed on androgen-deprivation therapy, often with or without prior chemotherapy, depending on local label and clinical situation.
- High-risk metastatic hormone-sensitive prostate cancer (mHSPC), where early intensification of systemic therapy with abiraterone plus steroids has been shown to improve survival and delay complications in appropriate patients.
- Selected patients with advanced disease where abiraterone-based therapy is considered clinically appropriate by the specialist team, in line with regional approvals and reimbursement rules.
The choice between abiraterone (Samtica 250 mg), chemotherapy, other androgen receptor–targeted agents or combinations is individualised and should always follow specialist recommendations based on evidence and patient-specific factors.
How Abiraterone Works in Chemotherapy
Although abiraterone is not a traditional cytotoxic chemotherapy, it is often discussed within the broader systemic treatment options for advanced prostate cancer. Abiraterone acetate, the active component of Samtica 250 mg, is converted in the body to abiraterone, which selectively and irreversibly inhibits the enzyme CYP17 (17α-hydroxylase/C17,20-lyase).
CYP17 is critical in androgen biosynthesis pathways in the testes, adrenal glands and tumour tissue. By blocking this enzyme, abiraterone reduces the synthesis of androgens such as testosterone and dihydrotestosterone, which prostate cancer cells rely on for growth and survival, even in castrate conditions. The profound reduction of circulating and intratumoural androgens helps slow tumour progression, improve PSA responses, delay skeletal events and prolong survival when used appropriately in metastatic prostate cancer.
Because CYP17 inhibition also affects mineralocorticoid pathways, abiraterone leads to a rise in mineralocorticoids, which is why Samtica 250 mg must be co-administered with low-dose prednisone or prednisolone to reduce the risk of hypertension, fluid retention and hypokalaemia.
Dosage & Administration
Samtica 250 mg abiraterone tablets must be prescribed and monitored by an oncologist or uro-oncologist experienced in advanced prostate cancer. The usual total daily dose of abiraterone is defined in the product information and may be given as multiple 250 mg tablets taken once daily. Tablets are usually taken on an empty stomach (for example, at least two hours after and one hour before food), as food can significantly alter abiraterone exposure.
Samtica 250 mg is always used together with low-dose prednisone or prednisolone, taken according to the schedule specified by your doctor. Continuing androgen-deprivation therapy is usually required. Regular monitoring includes liver function tests, blood pressure, electrolytes (particularly potassium) and signs of fluid retention or heart failure. Dose interruptions, reductions or discontinuation may be needed if significant toxicity or biochemical abnormalities occur. Patients should never change their abiraterone or steroid dose without specialist guidance.
Precautions
Before starting Samtica 250 mg, your specialist will assess your liver function, cardiovascular status, blood pressure, potassium level and overall fitness for systemic prostate cancer therapy. Abiraterone can worsen hypertension, hypokalaemia and fluid retention, so caution is required in patients with heart failure, coronary disease or other cardiovascular risk factors.
Liver function tests are checked regularly, as abiraterone can cause elevations in liver enzymes and, rarely, serious hepatotoxicity. The medicine is contraindicated in women who are or may become pregnant, and Samtica 250 mg is intended only for use in men. Handling instructions should be followed carefully, particularly by caregivers. Effective contraception is recommended for men with partners who may become pregnant because abiraterone can harm an unborn baby.
Abiraterone Side Effects
Common side effects
Common abiraterone side effects seen in patients taking Samtica 250 mg include fluid retention, ankle swelling, increased blood pressure, low blood potassium, fatigue, joint or muscle pain, hot flushes, diarrhoea, indigestion, cough and mild liver enzyme elevations. Many patients also report mild urinary symptoms, changes in appetite or sleep disturbance.
These effects are often manageable with dose adjustments, diuretics, potassium supplementation, blood pressure medicines, lifestyle measures and careful monitoring. Your oncology team will explain which symptoms to expect and when to contact the clinic.
Serious side effects
Serious abiraterone adverse effects require urgent medical attention and may include severe liver dysfunction with marked jaundice or very high liver enzymes, dangerous hypokalaemia leading to muscle weakness or cardiac arrhythmias, worsening heart failure or severe fluid overload, uncontrolled hypertension, severe shortness of breath or sudden chest pain. Rarely, severe allergic reactions can occur.
Patients should seek immediate medical help if they develop sudden weight gain with swelling, severe breathlessness, chest pain, fainting, marked jaundice, dark urine, confusion, muscle cramps with pronounced weakness or any other alarming symptom while taking Samtica 250 mg with steroids.
Storage
Samtica 250 mg abiraterone tablets should be stored in the original blister and outer carton below 25 °C, protected from moisture and direct heat. The pack must be kept out of sight and reach of children and should not be stored in humid environments such as bathrooms. Tablets should not be used after the expiry date printed on the carton and blister. Unused or expired medicine should be returned to a pharmacy or disposed of according to local cytotoxic/oncology waste guidance, not flushed or thrown in household rubbish.
Why Buy from Generic Meds Mart
Generic Meds Mart focuses on structured access to key prostate cancer therapies such as Samtica 250 mg abiraterone tablets. We partner only with licensed manufacturers and authorised distributors that follow recognised Good Manufacturing Practice and maintain traceable batch records. Each pack of Samtica 250 mg is supplied in sealed original oncology packaging so your treatment centre can verify brand, strength, batch number and expiry before dispensing.
Prices are clearly shown in USD, helping patients and clinics plan the cost of long-term metastatic prostate cancer therapy. Orders are shipped in neutral outer packaging without obvious references to abiraterone or prostate cancer, and where available, tracking details are provided so you and your team can coordinate treatment scheduling around delivery. Our customer support can help with ordering and logistics questions, but treatment decisions remain strictly between you and your oncology specialists.
Order Now
Before you buy Samtica 250 mg abiraterone tablets online from Generic Meds Mart, you must have a clear treatment plan from your oncologist or uro-oncologist. This should describe your diagnosis, stage, prior therapies, the role of abiraterone in your regimen, how many Samtica 250 mg tablets you will take each day, the dose of prednisone or prednisolone, and how often blood tests and monitoring visits will be scheduled.
Once your plan is agreed, your team can estimate how many packs of Samtica 250 mg (1 pack / 120 tabs) you need for your initial treatment period. You can then select the required number of packs on Generic Meds Mart, add them to your cart and complete secure checkout in USD. Your medicine will be shipped in discreet packaging with full product labelling. You should never start, stop or change Samtica 250 mg or your steroid dose without consulting your specialist, and any new or severe symptoms should prompt immediate contact with your oncology team or emergency services.
FAQ about Samtica (Abiraterone)
Q1: What is Samtica 250 mg used for?
Samtica 250 mg contains abiraterone acetate, an androgen biosynthesis inhibitor used with prednisone or prednisolone and ongoing androgen-deprivation therapy in men with metastatic castration-resistant or high-risk metastatic hormone-sensitive prostate cancer, as permitted by local approvals and guidelines.
Q2: Do I still need hormone injections if I take Samtica 250 mg?
In most protocols, abiraterone (Samtica 250 mg) is given on top of ongoing androgen-deprivation therapy, such as LHRH agonists or antagonists or surgical castration. You should not stop hormone injections or change your regimen unless your specialist clearly instructs you to do so.
Q3: Why must I take steroids with Samtica 250 mg?
Abiraterone blocks CYP17 and reduces cortisol production, which in turn increases mineralocorticoids. Low-dose prednisone or prednisolone is prescribed with Samtica 250 mg to replace some steroid hormone and reduce the risk of high blood pressure, fluid retention and low potassium linked to mineralocorticoid excess.
Q4: Can I take Samtica 250 mg with food?
Abiraterone exposure is strongly affected by food. Samtica 250 mg tablets are usually taken on an empty stomach, for example at least two hours after eating and one hour before the next meal, exactly as directed in your product leaflet and by your specialist. You should follow the same routine each day and not change it without medical advice.
Q5: How long will I need to stay on Samtica 250 mg?
Treatment duration with Samtica 250 mg varies. Many patients continue abiraterone therapy as long as they are benefiting and side effects remain manageable, but therapy may be stopped if the cancer progresses or unacceptable toxicity develops. Your oncology team will monitor PSA, imaging, symptoms and blood tests and will decide with you when to continue, pause or switch treatment.



Reviews
There are no reviews yet.